Page last updated: 2024-10-23

atenolol and Arrhythmogenic Right Ventricular Dysplasia

atenolol has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 2 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Arrhythmogenic Right Ventricular Dysplasia: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuznetsov, AB1
Elagin, OS1
Syrkin, AL1
Kuhn, A1
Kottkamp, H1
Thiele, H1
Schuler, G1
Hindricks, G1

Other Studies

2 other studies available for atenolol and Arrhythmogenic Right Ventricular Dysplasia

ArticleYear
[Cardiomyopathies with predominant right ventricular involvement].
    Kardiologiia, 2002, Volume: 42, Issue:5

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Arrhythmogenic Right Ventri

2002
[Idiopathic right ventricular tachycardia or arrhythmogenic right ventricular tachycardia?].
    Deutsche medizinische Wochenschrift (1946), 2000, Jun-02, Volume: 125, Issue:22

    Topics: Adult; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Atenolol; Bicycling; Card

2000